Corporate/M&A: Mainland China-based (International Firms) | Greater China Region

Alan Wang services a diverse clientele of foreign corporates from a variety of sectors, including automotive and pharmaceutical. He offers extensive experience in multi-jurisdictional M&A and private equity transactions, as well as joint ventures.

Kelly Gregory possesses considerable corporate expertise and regularly assists clients with inbound transactions, including M&A and joint ventures. She is also well regarded for her strength in outbound acquisitions.

Wang Yang has a notable corporate practice that services corporate and private equity firms. He is based in the firm's Beijing office, advising on sizable private equity investments, buyouts, strategic investments and share repurchases.

Charles Ching handles a range of transactional mandates, including joint ventures, privatisations and spin-offs. His clientele features investment firms as well as China-based and international corporates.

Xue Fang's wide-ranging practice spans M&A transactions, privatisations and private equity investments. She is based in the firm's Beijing office and maintains good working cooperation with clients in the USA, Hong Kong and the Cayman Islands.

Jack Wang leverages over 20 years of transactional experience to assist clients with cross-border disposals, M&A and joint ventures. His fluency in Mandarin and English equips him well to handle mandates on behalf of an international and China-based clientele.

James Chang serves Chinese-based companies and investors as well as multinationals, acting on cross-border acquisitions, privatisations and equity financings. He frequently advises technology, healthcare and insurance sector clients.

Nanda Lau heads the firm's corporate practice in China and advises multinational corporations on cross-border transactions, with a focus on joint ventures and acquisitions. She advises clients from the TMT, logistics, biotech, financial services and manufacturing sectors.

Zhang Ning focuses his practice on all manner of corporate transactions, from cross-border M&A and private equity transactions to disposals and spin-offs. He is sought after by financial services, education and technology industry clients.

Yue Qi has a practice encompassing private and public M&A, joint ventures, venture capital and going-private transactions.

Li Qiang in Shanghai assists PRC, Europe and US-based corporates and private equity firms with their inbound and outbound acquisitions and investments. He co-leads the corporate practice at DLA Piper and is a member of the Board of the American Chamber of Commerce in Shanghai.

Terence Foo focuses on transactions and mandates involving multiple jurisdictions. His work includes advising on acquisitions, commercial agreements and strategic partnerships. He has maintained a good working cooperation with clients from the automotive and energy sectors.

Greg Liu is based in the firm's Hong Kong office and frequently handles transactions for large corporates and investors. He has wide expertise in handling privatisations, disposals, acquisitions and private equity investments.

Li Ling is based in A&O Shearman's Beijing office and is noted for handling corporate transactions in the energy, natural resources and industrial sectors.

Li Ruomu of Cooley is an experienced corporate lawyer who is dedicated to mergers and acquisitions as well as private equity transactions. Her wide expertise also covers joint ventures and various forms of venture capital investment.

Ulrike Glueck of CMS is managing partner of the firm's Shanghai office in addition to being head of its corporate practice. She has a wealth of experience on advising on M&A matters, particularly those involving German parties.

Shen Yuxin is based in Beijing and has a broad corporate and M&A practice. He has several years' experience in handling cross border transactions and regulatory issues.

Yang Yi is a partner in the firm's Shanghai office and specialises in M&A, joint ventures and other transactions, particularly cross-border ones. He has a strong track record when it comes to the life science and manufacturing sectors.